Clinical Trials
6
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Development of a New Patient Reported Outcome Measure (PROM) to Assess Patient's Emotional Wellbeing, and Perceptions of Total Knee Replacement Surgery for the Treatment of Knee Arthritis
- Conditions
- Complete Questionnaires Following TKR Surgery
- First Posted Date
- 2024-09-05
- Last Posted Date
- 2024-12-16
- Lead Sponsor
- Invibio Ltd
- Target Recruit Count
- 150
- Registration Number
- NCT06585267
- Locations
- 🇬🇧
Chapel Allerton Hospital, Leeds, United Kingdom
A Post-market Clinical Study to Evaluate the Safety and Performance of the Carbon Fibre Reinforced Polyetheretherketone Metatarso-Phalangeal (MTP) Plate (CoLink® PCR MTP Plate) for the Treatment of Hallux Rigidus
- Conditions
- Hallux Rigidus
- First Posted Date
- 2023-01-20
- Last Posted Date
- 2025-04-30
- Lead Sponsor
- Invibio Ltd
- Target Recruit Count
- 40
- Registration Number
- NCT05692687
- Locations
- 🇺🇸
South Florida Foot and Ankle Center, Lake Worth, Florida, United States
🇺🇸University of Kansas Medical Centre, Kansas City, Kansas, United States
🇺🇸Mississippi Sports Medicine and Orthopedic Center,, Jackson, Mississippi, United States
Study to Evaluate the Clinical and Radiographic Outcomes of the BEE® HA Cage for Anterior Cervical Discectomy and Fusion
- Conditions
- Cervical Disc Degeneration
- First Posted Date
- 2022-11-30
- Last Posted Date
- 2025-04-30
- Lead Sponsor
- Invibio Ltd
- Target Recruit Count
- 51
- Registration Number
- NCT05631392
- Locations
- 🇩🇪
Bg Klinikum Bergmannstrost Halle, Halle, Germany
Qualitative Interviews With Healthcare Professionals
- Conditions
- Total Knee Replacement
- First Posted Date
- 2022-10-27
- Last Posted Date
- 2022-11-09
- Lead Sponsor
- Invibio Ltd
- Target Recruit Count
- 6
- Registration Number
- NCT05597046
- Locations
- 🇺🇸
AAKHS conference, Dallas, Dallas, Texas, United States
A Clinical Study to Evaluate Safety and Performance of PEEK-OPTIMA™ HA Enhanced.
- Conditions
- SpondylolisthesisRetrolisthesisDegenerative Disc Disease
- First Posted Date
- 2020-06-04
- Last Posted Date
- 2025-04-30
- Lead Sponsor
- Invibio Ltd
- Target Recruit Count
- 30
- Registration Number
- NCT04416321
- Locations
- 🇺🇸
Neurosurgical Associates of Lancaster, Lancaster, Pennsylvania, United States
- Prev
- 1
- 2
- Next